Life Sciences

Medtronic marketing investigated

Device Regulation Alert: Safety, Compliance and Reimbursement News, September 15, 2008

Medtronic became the fourth major manufacturer investigated for improperly marketing its bile duct stents, according to an AdvaMed article.

According to the article, Medtronic received a subpoena in late June around the same time as Johnson & Johnson, Boston Scientific, and Abbott Laboratories. The U.S. Attorney in Massachusetts is trying to determine whether the companies promoted the bile duct stents for unapproved use in blood vessels.

Comments

0 comments on “Medtronic marketing investigated

 

Most Popular

Related Articles